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In brief 
• Students in the Bristol Dental Hospital understood the links between HPV and 
oropharyngeal carcinoma and its vaccination process. 
• Students demonstrated that they believe oral healthcare practitioners have a role to 
play in health promotion regarding oral and oropharyngeal cancer but desired more 
teaching on the topic. 
• Students felt unprepared to discuss the disease and associated risk factors with 
patients but further clarification as to why is needed. 
 
Abstract 
 
 
Introduction Dental clinicians are in a position to educate their patients on the subject of 
HPV as part of a primary healthcare multidisciplinary team and to detect HPV related disease. 
Attention needs to be paid to dental undergraduate teaching on the topic. This study aims to 
ascertain awareness and opinions of our dental undergraduate students about HPV, its 
relation to oral health and its vaccine. Method A questionnaire was distributed to 
undergraduate dental students in clinical years 3, 4 and 5 of the BDS programme at Bristol 
Dental School. Results Dental students demonstrated an understanding of HPV and 
oropharyngeal cancer and expressed that they felt dentists should play a role in health 
promotion in relation to oropharyngeal cancers. They also wished for more teaching on the 
subject and suggested topic areas that they wished to know more about. Conclusion New 
teaching strategies on the topic of HPV should be considered for inclusion into undergraduate 
dental programmes and encompass both knowledge and communication skills training to 
prepare future dentists for their role in confronting this preventable disease. 
 
 Introduction 
 
The Human Papilloma Virus (HPV) is established as an aetiological risk factor for oropharyngeal 
cancer.1 The number of cases of oropharyngeal cancer in the UK has risen significantly over the last 
two decades with the age-specific greatest increase in incidence seen in the 40-69 year old age 
group2 and a similar increase in cases has been noted in other countries.3 HPV, in particular HPV-
16, has seen a significant rise in association with oropharyngeal cancer over the last decade4, is 
identified in approximately 50-60% of cases.2,4–6 HPV is thought to explain the pattern of 
oropharyngeal cases in young, heterosexual male, non-smoking, low alcohol drinking patient 
cohort. Evidence suggests transmission of HPV is via high-risk sexual activity7 and is associated the 
number of sexual partners and oral sex partners over a lifetime.8–10 Tumour HPV status is 
considered to be a major prognostic factor for patients with oropharyngeal carcinoma11 with 
survival for patients with HPV positive tumours being better.12,13 Management of patients with 
HPV-related oropharyngeal cancer is a high interest area of current research14 as effective 
treatment modalities differ from their non-HPV-related counterparts. 
 
Oral health professionals can play a role in the prevention of HPV-related oropharyngeal cancers by 
educating patients about the risks of HPV transmission, instruct about lifestyle change and by 
encouraging patients and their relatives to participate in HPV vaccination programmes.15–17 There 
is a view in the United States that dental healthcare providers should be involved in education of 
their patients about HPV and its link to oropharyngeal cancers18,19 and some suggest oral health 
professionals should be at the forefront of confronting the ‘HPV related oropharyngeal cancer 
epidemic’.18 Given that 28.9 million people accessed NHS dental care in the 24 months ending 31 
Dec 201620, dental teams have a real opportunity to engage with a significant number of people 
about this escalating disease.  
 
Since 2008, the current HPV vaccination programme in the UK has included girls aged 11-13, aimed 
at prevention of cervical cancers. Thus far it is reported to have decreased cancer rates by 86% in 
those women eligible for the vaccination as adolescents.21 Many organisations, including the British 
Dental Association22 are campaigning to include vaccinations for adolescent boys as well. The HPV 
vaccination became available for men who have sex with men in April 2018 after successful pilots in 
the UK23 and, most recently, the HPV vaccine has been proved to be cost effective in teenage boys 
and it will soon be offered to this cohort.24 
 
Articles on the subject of HPV have been presented more recently in dental literature in the UK25–28 
and a recent study concluded that UK dental students lack confidence in communicating with 
patients about HPV.29 It is clear that educational interventions are required to keep all dental 
professionals up to date with the rapidly changing landscape of oral and oropharyngeal cancer30 in 
addition to training in communication skills to connect sensitively with their patients about 
potentially delicate subjects around sexual activity.  
 
The present study has been conducted, as part of our teaching evaluation and development process, 
with an aim to ascertain the current awareness and opinions of HPV and its vaccine among our 
dental undergraduate students. The outcome of the study will inform the undergraduate dental 
teaching programme review process to ensure our students graduate to carry out effective health 
promotion on this subject.  
 
Methods 
 
A cross-sectional study was performed among undergraduate dental students in years 3, 4 and 5 of 
the five-year Bachelor of Dental Surgery programme at Bristol Dental School. A questionnaire was 
developed using previous literature8,29 and validated by means of a round table discussion 
(Appendix 1). Ethical approval was obtained via the University of Bristol, Faculty of Medicine & 
Dentistry Ethics Committee.  
 
The clinical dental undergraduate students were selected because all these students had received 
some teaching about HPV, the extent of which depending on which year of the programme they 
were enrolled in. The students were advised by e-mail one week ahead of questionnaire 
distribution that they would be surveyed using a hard copy of the questionnaire at the end of a 
specified lecture. Students in all years were given the opportunity to leave without completing the 
survey. Questionnaires were deposited by students in to a drop box after they had completed them. 
Completed questionnaires were immediately entered in to a secure password protected University 
accessed database. Descriptive analysis was applied to the data. 
 
Questions were developed to acquire qualitative data to assess dental students’: 
• Current awareness about HPV and its link to oropharyngeal cancer (yes/no answers), 
• Knowledge of the methods of HPV transmission (single best answer). 
• Knowledge of the current UK vaccination schedule (single best answer).  
• Opinions on the importance of the role that general dental practitioners play in health 
promotion related to oral and oropharyngeal cancer (4 point Likert scale).  
• Views on how much more information regarding HPV and its vaccine they would like to be 
taught (4 point Likert scale) 
 
In addition, a free text area was included to gain further information regarding what else students 
would like to know about HPV.  
 
Results 
 
Response rates 
 
A total of 167 questionnaires were returned from the 211 students across the 3 clinical years, 
giving a response rate across all years of 79%. Students from third year responded highest with a 
92% response rate, followed by year 5 at 74% and then year 4 with a response rate of 72%. The 
absolute number of responses follows this trend with 61, 55 and 51 responses respectively. 
  
Responses to questions regarding HPV awareness 
 
The results to the questions relating to students’ awareness of HPV and its link to oropharyngeal 
cancer, awareness of HPV transmission and the HPV vaccine are illustrated in Figures 1 to 3. There 
was a slight decrease in responses to individual questions. The questions represented by Figure 1 
had two respondents not answer and Figure 3 lacked one answer. In summary: 93% of students 
knew HPV and cause oropharyngeal cancer, 71% knew it could be contracted via oral-genital sex 
and 83% correctly identified the cohort eligible for the vaccine under the NHS at the time. With 
regard to the latter point, half of those who responded incorrectly, chose answers that included the 
correct cohort. 
 
Role of the dentist 
 Students were asked how important they thought the role of the dentist is in health promotion 
related to oropharyngeal cancer. In total 143 (86%) of students responded that the role of the 
dentist was either important or very important. Only two students, both from year 3, responded that 
the dentist’s role was not important at all. The results are illustrated in Figure 4.  
 
Dental education 
 
When the students were asked how much more they felt they needed to know about HPV and its 
vaccine, 139 (83%) of 167 responders answered ‘some more’ or ‘lots more’ as illustrated in Figure 
5. Only three students (2%) felt they knew enough about HPV and its vaccine. 
 
The free text answers to ‘What more would you like to know about HPV and its relation to oral 
health?’ were categorised into ‘knowledge’ and ‘communication’ themed comments. The responses 
are summarised in Table 1. Across all three years, there is a rough 2:1 ratio between students’ 
desire for more knowledge of HPV and its vaccine and teaching in communication of these topics 
with their patients.  
 
Respondents tended to show a desire for more knowledge in prevention, vaccination and risk 
management. With regards to communications, students desired teaching about how and what to 
be advising to their patients about HPV and its vaccination. 
 
Discussion 
 
The position that the oral healthcare professional has a role to play in health promotion regarding 
HPV, oral and oropharyngeal cancers and its vaccine clearly resonates with our undergraduate 
dental students; all but one registered that it has importance. It follows that for this to be possible, 
knowledge of the virus and its sequelae should be taught to students so they can adopt this role 
when they begin to practice. It is worth noting that the question did not have an answer for equally 
important (i.e. a shared responsibility) between dental and medical team.  
 
The question arises as to what dentists need to know about HPV, how they are expected to use that 
information to care for their patients, and indeed how much time is dedicated to this topic in a busy 
undergraduate dental curriculum. A learning outcome relating to health promotion and disease 
prevention in the GDC’s dental undergraduate curriculum document ‘Preparing for practice’ states 
that dentists are expected to ‘provide patients with comprehensive and accurate preventive 
education” and “underpin all patient care with a preventive approach that contributes to the patient’s 
long-term oral and general health’31. With no specific guidance available, some authors have 
attempted to propose a level of knowledge about HPV that dentists should aim for, focussing on 
understanding the pathophysiology of HPV and oropharyngeal cancer, associated risk factors and 
on available vaccination programmes.1,7,8 Others advocate that national organisations representing 
oral health professionals should develop campaigns to offer education on HPV as part of continuing 
professional development.18,30  
 
In light of no reliable screening tools for oral HPV, prevention and early detection of disease is 
paramount. Education about lifestyle risk factors, vaccination programmes and the virus itself 
should be available to patients if they enquire, especially if the patient falls within the ever-
expanding cohort of those who are offered the vaccination on the NHS. With respect to detection, 
practitioners should be able to identify oral and oropharyngeal carcinomas at their early stage and 
provide appropriate referral and council. 
 
Most of the students (93%) surveyed had an understanding that HPV and oropharyngeal cancers 
are causally linked, however, just under a third – across all year groups - did not know that it could 
be contracted via oral-genital sex. This is significant as lack of knowledge about transmission may 
lead to patients being misinformed about their actual risk of the disease. Van der Valk and Walker17 
found similar results in 2014, finding that two-thirds of newly qualified dentists in the Berkshire 
area felt poorly trained on discussing HPV with their patients. It is apparent, then, that there is a 
need for further education around this topic. A wider-reaching study including multiple institutions 
would be beneficial and may highlight places where students are very well prepared to deal with 
HPV. 
 
Fortunately, the vaccination programme in the UK was better understood with 91% of respondents 
choosing an answer including the correct cohort. This is important because the danger with poor 
knowledge of vaccination programmes is lack of referral and education, not over-education or over-
referral. However, this should not lead to complacency as new developments in the eligible 
vaccination cohort mean continued education is needed. 
 It is not just the author’s opinion, however, that more teaching is needed here. The majority of our 
students expressed that they felt they needed to know ‘some more’ or ‘lots more’ about HPV and its 
vaccine (Figure 5) to inform patients. There were many knowledge themed free text comments 
supporting this (Table 1) such as what are the ‘risks and prevalence?’ of HPV and ‘what can we do to 
reduce the risk?’. Acquiring this data about gaps in our students’ knowledge is key to improve our 
teaching programme so that students are given the information they need to help educate their 
patients in the future.  
 
Dental students are conventionally well trained in discussing risk factors related to oral cancer with 
patients, such as tobacco use and alcohol consumption29 however, HPV and its relation to 
oropharyngeal cancer is a relatively new topic in the dental programme. There were several 
communication themed free text comments that demonstrated students may not be confident in 
communicating with patients about HPV, for example ‘how do you talk to patients about HPV?’ and 
‘when appropriate to bring this up with patients?’ (Table 1). A recent study found that only 14% of 
dental students felt confident in discussing the risks of HPV in relation to oral health and 16% felt 
confident in advising on HPV vaccination programmes.29 It is not clear, however, that this is a 
function of students’ lack of knowledge more than the fact that discussion of oral-genital sex, cancer 
and high-risk lifestyles is inherently difficult. Particularly when those patients are young girls, and 
soon boys, under the age of 18. The ability to broach these topics professionally and with 
confidence is unlikely to come from the classroom and more from dedication communications 
teaching and experience in practice.  
 
It is beneficial for patients and practitioners alike that dental education does not lag behind it’s 
practice, as some authors have alluded to in other areas dentistry.32 Given that this is a quickly 
changing field, there is potential here for more modern and alternative teaching methods, such as 
online courses or seminars, that can be easily spread, digested at leisure and updated with new 
developments remotely. Further research into why students and dentists are not comfortable 
discussing the above topics, and indeed whether this feeling persists with veteran oral healthcare 
professionals, would help guide both content and teaching methods and delivery. 
 
Conclusion 
 
The rise in HPV-related oropharyngeal cancer is recognised by the dental profession and attention 
must be given to training in this topic in contemporary dental undergraduate programmes. The 
study highlights that, despite a good acknowledgment of the disease and its sequelae, students from 
the Bristol Dental Hospital would like further teaching regarding the communication and 
prevention of HPV. Undergraduate dental programmes should aim to incorporate training in 
knowledge about HPV, as well as communication skills teaching, focussed on prevention, referring 
patients appropriately and answering patients’ questions in order to educate them as part of a 
multidisciplinary primary healthcare approach to tackling this preventable disease. Future studies 
should assess novel ways to improve dental students’ knowledge and awareness of oral and 
oropharyngeal cancer, including HPV as a risk factor, and examine methods to develop dental 
students’ confidence in communicating with patients on the subject.  
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Tables 
 
 
Table 1: Tabulated free text responses by year group 
Year 3 
Knowledge Risk factors/signs/symptoms 
I don’t really know anything, just that it can occur 
Likelihood of HPV contraction, chances of Ca development, mode of transmission 
Everything. The only health link I was aware of was HPV and cervical cancer 
How to prevent infection. The exact implications of HPV 
How to prevent infection. Treatments 
Prevalence. 
What can we do to reduce the risk? 
Signs and symptoms, consequences, action that needs to be taken 
Risks and prevalance 
Communication Where to advise patients to gain more info/vaccination 
A lecture on it and how to give advice 
What to tell patients 
How to approach subject with patient 
How can we make people more aware without worrying them? 
 
Year 4 
 
Knowledge Vaccines available 
How to identify risks to patients and clinical signs of symptoms in patients 
Be able to confidently diagnose oral warts 
The risks / benefits of HPV vaccine. How it acts. Who it's available to. 
Causes. How caught. Consequences. Treatment 
Causes, signs and symptoms, prognosis, when to refer 
Exactly how it impacts oral health and how big the risk is for oropharyngeal cancer 
We have not had any practical teaching  
Its aetiology, effects, public health info and programmes currently in place 
Key presentation signs. 
Risks of vaccine. Stats. 
Communication How to communicate this risk to patients with reference to HPV. Communication training to extract this info  
from patients 
We haven't had much teaching on HPV communication skills, 
How do you talk to patients about HPV? 
Advice to give patients. Who to target the advice towards. ?screening programme 
Ways to discuss with patients their risk of oropharyngeal cancer. 
When appropriate to bring this  up with patients 
Who you should tell and when 
How to discuss the issue sensitively with patients 
 
Year 5 
 
Knowledge About the possible vaccines - when they are available and what protection they convey the patients 
About the vaccine, Epidemiology of HPV and oral cancer 
Exact effects 
The vaccine 
Management 
What to do if you have a problem 
HPV prevalance, treatment, % of people that develop cancer, screening/detection 
How to prevent. Who to talk to about it. Consequences and risk rates 
Statistics. Can an oral 'wart' progress to cancer? 
Communication What to tell patients 
Advising patients 
What we should be advising to patients 
How to advise patients 
What should be advise patients to reduce risk? Who should we give this advice? 
 
 
